Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Yoshikazu Kuribayashi"'
Autor:
Raita Araki, Ryosei Nishimura, Anri Inaki, Hiroshi Wakabayashi, Yasuhito Imai, Yoshikazu Kuribayashi, Kenichi Yoshimura, Toshinori Murayama, Seigo Kinuya
Publikováno v:
Asia Oceania Journal of Nuclear Medicine and Biology, Vol 6, Iss 2, Pp 161-166 (2018)
Objective(s): High-risk neuroblastoma is a childhood cancer with poorprognosis despite modern multimodality therapy. Internal radiotherapy using131I-metaiodobenzylguanidine (MIBG) is effective for treating the disease even if it isresistant to chemot
Externí odkaz:
https://doaj.org/article/52a92d0c8f12444a89d654bbbe51e782
Autor:
Anri Inaki, Tetsuya Higuchi, Seigo Kinuya, Kenichi Yoshimura, Yoshikazu Kuribayashi, Toshinori Murayama, Tohru Shiga, Yasuhito Imai, Megumi Jinguji
Publikováno v:
The Journal of Medical Investigation. 64:205-209
Objective Pheochromocytoma and paraganglioma (PPGLs) are rare neuroendocrine tumors derived from the adrenal medulla or extra-adrenal paraganglioma from extra-adrenal chromaffin tissue. Although malignant PPGLs has miserable prognosis, the treatment
Autor:
Yoshinori Hasegawa, Katsuyuki Kiura, Toshinori Murayama, Takahiro Kawakami, Shizuko Takahara, Kenichi Yoshimura, Seiji Yano, Shinji Takeuchi, Katsuhiko Nagase, Yoshikazu Kuribayashi, Koichi Goto, Yasuhito Imai, Takashi Seto, Makoto Nishio, Miyako Satouchi
Publikováno v:
The Journal of Medical Investigation. 64:317-320
Background The rearranged during transfection (RET) fusion gene was discovered as a driver oncogene in 1-2% of non-small cell lung cancers (NSCLCs). Alectinib is an approved anaplastic lymphoma kinase (ALK) inhibitor that may also be effective for RE
Publikováno v:
Drug research. 69(10)
Objective The aim of this study was to determine promising treatment options for human inflammatory dilated cardiomyopathy using a computational drug-repositioning approach (repurposing established drug compounds for new therapeutic indications). Bac
Autor:
Shinji, Takeuchi, Toshinori, Murayama, Kenichi, Yoshimura, Takahiro, Kawakami, Shizuko, Takahara, Yasuhito, Imai, Yoshikazu, Kuribayashi, Katsuhiko, Nagase, Koichi, Goto, Makoto, Nishio, Yoshinori, Hasegawa, Miyako, Satouchi, Katsuyuki, Kiura, Takashi, Seto, Seiji, Yano
Publikováno v:
The journal of medical investigation : JMI. 64(3.4)
The rearranged during transfection (RET) fusion gene was discovered as a driver oncogene in 1-2% of non-small cell lung cancers (NSCLCs). Alectinib is an approved anaplastic lymphoma kinase (ALK) inhibitor that may also be effective for RET fusion-po
Publikováno v:
Folia Pharmacologica Japonica. 127:375-380
Publikováno v:
Biological & Pharmaceutical Bulletin. 24:767-771
The aim of this study was to determine the relationship between the neuroprotective effect of SM-20220 (N(aminoiminomethyl)-1-methyl-1H-indole-2-carboxamide methanesulfonate) and the timing of its administration in an experimental stroke model. Two h
Autor:
Mizue Nishioka, Nobuko Kawamura, Natsuko Itoh, Naotsugu Horikawa, Naohito Ohashi, Yoshikazu Kuribayashi, Kazuki Matsui
Publikováno v:
Japanese Journal of Pharmacology. 85:271-277
Endothelial cells play an important role in the physiologic homeostasis of the cerebral circulation. Previously, we showed that the Na+/H+ exchanger (NHE) inhibitor SM-20220 (N-(aminoimino-methyl)-1-methyl-1H-indole-2-carboxamide methanesulfonate) im
Autor:
Naotsugu Horikawa, Yoshikazu Kuribayashi, Mizue Nishioka, Naohito Ohashi, Kazuki Matsui, Natsuko Itoh
Publikováno v:
Pharmacology. 63:76-81
The aim of this study is to clarify whether the activation of a Na+/H+ exchanger (NHE) is tightly concerned with neuronal and glial cell injury induced by ischemia using a selective NHE inhibitor, SM-20220 (N-(aminoiminomethyl)-1-methyl-1H-indole-2-c
Autor:
Shinichi Nakajima, Makoto Katori, Yoshitada Yajima, Hiroshi Ito, Izumi Hayashi, Toshiaki Okumura, Yoshikazu Kuribayashi, Masataka Majima
Publikováno v:
Clinical and Experimental Pharmacology and Physiology. 27:80-87
SUMMARY 1. To determine whether the antihypertensive response in deoxycorticosterone acetate (DOCA) salt-treated rats was mediated by kinins on the luminal side of renal tubules or in the circulation, selective urinary kininase inhibitors were admini